Announcement on Using Partial Idle Raised Funds to Temporarily Supplement Current Capital
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference: View Attachment
Announcement on Using Partial Idle Raised Funds to Temporarily Supplement Current Capital
Filed with SSE ·
6ix hasn’t read this filing yet.
Shandong Lukang Pharmaceutical Co., Ltd. on 6ix
Earlier from Shandong Lukang Pharmaceutical
- Announcement on the Results of Issuing Shares to Specific Objects and Changes in Capital Stock
- Announcement on the Company and Its Wholly-Owned Subsidiary Signing the Fundraising Special Account Custody and Supervision Agreement
- Indicative Announcement on the Issuance of A-shares to Specific Objects in 2024
- Announcement on Signing Trademark License Agreement with Related Parties and Related Party Transactions
- Announcement on Obtaining Government Subsidies
Later from Shandong Lukang Pharmaceutical
- Earnings Preannouncement for 2025
- Announcement on "Corporate Value and Return Enhancement" Action Plan
- Announcement on Progress in Receiving Land Collection and Storage Compensation for the Southern Factory Area
- Announcement on Acquisition of Drug Registration Certificate by a Holding Subsidiary
- Announcement on the Holding Subsidiary Obtaining the Supplementary Application Approval Notice for Sildenafil Citrate Tablets and Becoming the Marketing Authorization Holder of the Drug
Follow Shandong Lukang Pharmaceutical into a list and get an email when it puts out news.
Follow Shandong Lukang Pharmaceutical